Mice infected with DENV and treated with Met-RANTES, a potent CCR5 inhibitor, were found to have lower viral load and increased survival, thus indicating that inhibition of the CCL5/RANTES interaction through CCR5 may be an important therapeutic target in dengue [43]. Here, CCR5 is linked to dengue disease.